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Abstract The purified serotonin transporter (SERT) was
spread at the air/water interface and the effects both of its
surface density and of the temperature on its interfacial behavior
were studied. The recorded isotherms evidenced the existence of a
stable monolayer undergoing a lengthy rearrangement. SERT/
ligand interactions appeared to be dependent on the nature of the
studied molecules. Whereas an unrelated drug (chlorcyclizine)
did not bind to the spread SERT, it interacted with its specific
ligands. Compared to heterocyclic drugs, for which binding
appeared to be concentration-dependent, a ‘two-site’ mechanism
was evidenced for pinoline and imipramine.
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1. Introduction
In nerve cells, platelets and gut enterochroma⁄n cells, se-
rotonin (5-hydroxytryptamine, 5-HT) is taken up by a high-
a⁄nity transporter, serotonin transporter (SERT), a member
of a large superfamily of homologous transporters that are
predicted by hydropathy analysis to contain 12 transmem-
brane-spanning domains (TMDs), and that use the biomem-
brane Na and Cl3 gradients as a source of energy ([1] for
review). SERT is most closely related to transporters speci¢c
for the other biogenic amines dopamine and norepinephrine.
These three monoamine transporters are the molecular targets
of important psychoactive drugs, including cocaine, antide-
pressants and amphetamines. Apart from expression [2] and
site-directed mutagenesis [3] studies, we took advantage of our
previous puri¢cation to homogeneity of SERT from human
platelets [4] to further characterize this puri¢ed SERT using
biophysical techniques. It was thought that they may provide
new insights into the mechanism and regulation of the electro-
neutral transport of 5-HT.
2. Materials and methods
2.1. Materials
Imipramine, chlorcyclizine, cocaine, pinoline and 3,4-methylene di-
oxymethamphetamine (MDMA) were purchased from Sigma (Saint
Louis, MI, USA), [3H]MDMA from Amersham (Buckinghamshire,
UK), [3H]imipramine, [3H]paroxetine and [125I]3L-(4-iodophenylpro-
pene-2L-carboxylic acid methyl ester) (RTI) from New England Nu-
clear (Boston, MA, USA). Indalpine and paroxetine were a gift from
Dr. V. Mutel (Ho¡man-LaRoche, AG., Basel, Switzerland).
[3H]Pinoline was synthesized by two of us (J.C. and H.M. at the
NTLF). Human platelet membranes and puri¢ed SERT, as well as
membranes from human brain cortex were prepared as previously
described [4,5]. Ultrapure water was obtained by osmosis from a
MilliRO6 Plus Millipore apparatus and then double-distilled from
permanganate solution in an all-Pyrex apparatus. Sodium chloride
(150 mmol/l) and sodium phosphate (10 mmol/l) used to prepare bu¡-
er solutions (pH adjusted to 7.40) were Normapur from Prolabo
(Paris, France). All glassware was cleaned by a sulfochromic mixture
and then abundantly rinsed with distilled water.
2.2. Binding experiments
[3H]MDMA, [3H]imipramine, [3H]paroxetine, [125I]RTI and
[3H]pinoline assays were performed as previously reported in [2,4^
7]. Prism software (GraphPad, San Diego, CA, USA) was used to
analyze all kinetic, saturation and competition data.
2.3. Surface tension measurements
The surface tension measurements at equilibrium (at constant area)
were performed by the Wilhelmy plate method as previously described
in [8,9]. The interfacial behavior of the SERT protein at the interface
was inferred from the change in surface tension after protein deposi-
tion onto the bu¡er subphase. Any tested ligand was dissolved into
the bu¡er and its adsorption at the air/water interface was assessed by
measuring the decrease in surface tension with time. The surface pres-
sures of a SERT monolayer (ZP) and of a considered ligand (ZL) were
deduced from the Z= Q03Q relationships, where Q0 stands for the sur-
face tension of the bu¡er solution and Q is the surface tension ob-
served in the presence of a spread protein or an adsorbed ligand
monolayer. The experiments were conducted in an enclosed chamber
and the cell was thermostated at a chosen temperature. All reported
surface tension values were means of at least three measurements. The
accuracy of the measurements was estimated to be þ 0.2 mN/m.
2.4. SERT/ligand interactions at the air/water interface
SERT molecules were spread to form a monolayer (1.5 Wg/cm2)
onto a ligand-containing subphase and the surface tension was re-
corded as a function of time until it reached equilibrium (ZT).
When a ligand was surface inactive, an additional surface pressure
(ZPL) was observed as its molecules interacted with the protein mono-
layer (ZT = ZP+ZPL). When a drug was surface active, surface pres-
sure changes due to its adsorption at the free air/solution interface,
ZL, had to be taken into account. In the presence of the SERT mono-
layer, the reduction of the available space at the interface would lead
to a ZL0 value lower than ZL. Thus, the interaction between a surface
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active speci¢c ligand and the SERT could be described by the equa-
tion:
ZT  ZP  ZL0  ZPL 1
where ZL0 and ZPL are the unknown quantities. An approximation was
made by considering that ZL0 = ZL. In this case, the surface pressure
ZPL resulting from the speci¢c interaction between the protein and its
ligands was underestimated.
The ability of a ligand to induce conformational rearrangements of
the SERT were inferred from the values of ¢rst rate kinetic constants
obtained by means of Eq. 2 which describes interfacial events follow-
ing protein spreading [10] :
ln
Z eq3Z t
Z eq3Z 0  3kt 2
where Zeq = ZP+ZPL, Zt is the surface pressure change at time t, Z0 the
initial surface pressure, and k is the kinetic constant.
3. Results
3.1. Interfacial behavior of the SERT
As previously reported, the puri¢ed SERT may be spread at
the air/water interface of a bu¡er solution and forms a mono-
layer [9]. Its interfacial behavior was found to be dependent
on the surface density (Fig. 1). At 21.5‡C, the surface pressure
increased rapidly at low surface coverages until 1.5 Wg/cm2
and then above this surface density, only a slight increase in
the surface pressure was observed. The e¡ect of temperature,
shown in the inset to Fig. 1, clearly indicates that the higher
the temperature, faster the rate at which the maximum surface
pressure was reached. In addition, the adsorption pro¢les
were di¡erent one from another. Whereas at 35‡C the Z^
time curve resembled the pro¢le of a globular protein ad-
sorbed at the air/water interface [11], at 21.5‡C, the initial
increase in the surface pressure (A), was followed by a short
equilibrium step (from A to B) and then by a slow pressure
increase (from B to C) which lasted several hours. However,
at both temperatures, the Z values after 20 h following SERT
deposition converged to an almost identical value. The stabil-
ity of the SERT monolayer was checked by performing suc-
cessive compression^expansion^compression cycles under dy-
namic conditions, using a Langmuir trough. They yielded
identical Z^A pro¢les (data not shown).
3.2. SERT/ligand interactions
3.2.1. Binding experiments in solution. Extending our pre-
vious report [4], in Table 1 are the Kd values summarized for
each considered ligand applied to di¡erent SERT-containing
materials. From these data, it is clear that the binding e⁄-
ciency splits into two groups, one with Kd values below 10 nM
(paroxetine, imipramine and indalpine) and another one with
Kd values above 100 nM (cocaine or RTI, MDMA and pino-
line).
3.2.2. Binding at the air/water interface. The interaction of
SERT with two speci¢c ligands (paroxetine and indalpine)
and with the unrelated ligand (chlorcyclizine, an anti-hista-
minic) was also studied and the results are shown in Fig. 2.
It is apparent that speci¢c interactions with SERT depended
both on the ligand concentration in solution and on the af-
¢nity of the ligand for the transporter. The response to the
ligand presence in the subphase was also selective. When
SERT was spread onto a paroxetine solution (8U1035 M
corresponding to ZL = 7.2 mN/m), an increase in the surface
pressure lasted for several hours. Conversely, the adsorption
of chlorcyclizine (1.3U1035 M corresponding to the same
ZL = 7.2 mN/m) to a SERT monolayer led to negative values
of ZPL. Since no speci¢c interaction was expected in this case,
ZPL should be considered insigni¢cant. The observed negative
values are related to the surface activity of the ligand and to
the fact that the ligand contribution to the change in surface
pressure, ZL0 , was taken to be equal to ZL. The increase in
surface pressure observed after several hours was most prob-
ably due to the rearrangement of the chlorcyclizine^SERT
mixed monolayer. A similar behavior was observed in the
reverse situation where a SERT speci¢c ligand (indalpine)
was injected beneath a non-speci¢c protein (bovine serum
albumin) monolayer (the results are not shown here). The
interaction of pinoline (a surface active molecule at a concen-
Fig. 1. Surface pressure (ZP) of the SERT as a function of its
surface density at 21.5‡C. Inset: surface pressure (ZP) of the SERT
as a function of time and at two temperatures (F : 21.5‡C and
b : 35‡C).
Table 1
Kd values for ligand binding to the SERT in brain, platelets and in solution, and kinetic constants (k) for SERT/ligand interaction at the air/
solution interface (kSERT = 0.5176 þ 0.046 h31)
Ligands Kd in brain (nM) Kd in platelets (nM) Kd puri¢ed SERT (nM) k puri¢ed SERT (h31)
Imipramine 1.25 þ 0.08 1.54 þ 0.15 1.73 þ 0.13 11.64 þ 1.54
Paroxetine 0.08 þ 0.01 0.25 þ 0.07 0.18 þ 0.06 2.41 þ 0.37
Indalpine 0.96 þ 0.15 1.20 þ 0.29 1.31 þ 0.23 3.14 þ 0.44
Pinoline 572 þ 73 175 þ 18 217 þ 17 0.55 þ 0.20
RTI 217 þ 23 446 þ 54 511 þ 52 ^
cocaine ^ ^ ^ 0.27 þ 0.15
MDMA 2067 þ 139 1887 þ 169 s 1 mM ^
Chlorcyclizine 0.22 þ 0.04
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tration above 1035 M) with SERT has been studied as a
function of pinoline concentration (Fig. 3). At the low surface
coverage (0.5 Wg/cm2), no speci¢c interaction could be evi-
denced even at high pinoline concentrations in the subphase.
At the higher surface coverage (1.5 Wg/cm2), a triphasic be-
havior was observed and depended on the concentration of
the ligand. An increase in the surface pressure corresponding
to a speci¢c interaction occurred, reaching a maximum at
5U1035 M of pinoline. Above this threshold value, the de-
crease in Z was observed until it reached a zero Z value at
about 1034 M. A similar mechanism to that with pinoline was
observed also with imipramine at its high solution concentra-
tion (5U1034 M). Cocaine interacted with the transporter
monolayer only at high concentrations and the increase in
surface pressure was limited to 2 mN/m, above 5U1034 M.
In the range of the studied concentrations, 5U1035^
5U1033 M, no binding of MDMA was detected.
4. Discussion
The cloning of rat, mouse and human SERT revealed pro-
teins sharing a common, putative 12 TMD structure (highly
hydrophobic domains). In this model, the extended N- and
C-terminals were assigned to the cytoplasm, because a hydro-
phobic N-terminus displaying the characteristics of a signal
peptide was missing. The cytoplasmic regions contained puta-
tive phosphorylation sites which were used for the regulation
of transport activity [12]. In addition, a long putative extra-
cellular loop containing N-glycosylation sites was conserved
between TMDs 3 and 4. The predicted 12 K-helices of the
SERT confer to it an ability to spread at the air/water inter-
face from a bu¡er solution and to form a stable monolayer.
The interfacial behavior of the protein has been shown to be
temperature, concentration and time-dependent. These results
strongly suggest that protein rearrangement after the deposi-
tion lasted several hours until an equilibrium was reached.
Indeed, Graham and Phillips [10] have demonstrated that
the surface pressure of an adsorbed protein layer may increase
for more than 10 h even if its surface concentration did not
change. Also Tronin et al. [13] showed that protein molecules
injected beneath a protein monolayer exchanged with those of
the monolayer to a very limited degree. Most probably, the
presence of macromolecules deposited at the interface hin-
dered adsorption of molecules of the same species dissolved
in the subphase. This would indicate that progressive rear-
rangement of protein molecules rather than their dissolution
in the subphase and subsequent adsorption at the interface
accounted for the lengthy times necessary to level o¡ surface
pressure values (B^C section in the inset to Fig. 1).
Speci¢c binding is based on molecular recognition of li-
gand^protein complementary sites. These complementary sites
may only exist if a protein is capable of preserving its con-
formation. As the SERT was capable of binding most of its
ligands, the results of the present work clearly demonstrate
that the protein spread from a bu¡er solution onto a bu¡er
subphase maintained, at least partially, its original conforma-
tion. However, it should be stressed that whereas binding
experiments provided information on the a⁄nity of the pro-
tein for a ligand through the determination of the Kd values,
the measured surface tension variations accounted rather for
SERT conformational changes induced by ligand binding. At
the air/solution interface, the arrangement of SERT is con-
trolled by its in£exible structure and by the hydrophobic/hy-
drophilic constrains of the environment. The transport func-
tion is, obviously, suppressed. However, we have shown here
that, at the surface density of 1.5 Wg/cm2, SERT molecules
were con¢ned into a favorable conformation that enabled the
speci¢c binding of ligand molecules.
From our previous work [9] and also from the above re-
ported results, it was apparent that the 5-HT and MDMA did
not produce any surface pressure change. These two molecules
are also the only two tested molecules that SERT is capable to
transport. Indeed, MDMA (‘ecstasy’) and PCA, as well as
Fig. 2. Interaction of SERT with heterocyclic molecules. E¡ect of
(a) ligand concentration, (b) ligand a⁄nity for the transporter and
(c) ligand speci¢city, on the surface pressure response.
Fig. 3. Interaction of SERT with pinoline. In£uence of SERT sur-
face density and of pinoline bulk concentration on the change in
surface pressure.
FEBS 23500 30-3-00
V. Faivre et al./FEBS Letters 471 (2000) 56^6058
non-neurotoxic amphetamines, have been found not only to
competitively inhibit 5-HT transport into human platelets
with high a⁄nity, but also to stimulate previously accumu-
lated [3H]5-HT e¥ux from these platelets by reversed plasma
membrane transport [14]. The ¢nding that both amphetamine-
mediated processes were Na-dependent and imipramine-sen-
sitive was consistent with a model in which amphetamines
were transported by SERT. This in turn implicates that
SERT is a 5-HT^amphetamine exchange system. Recently,
targeted gene disruption has shown that SERT is a main
target of action of MDMA because the locomotor-enhancing
e¡ect of MDMA was totally absent in mice lacking SERT [7].
Moreover, SERT has been shown to co-transport one Na
and one Cl3 ion with each 5-HT molecule per transport cycle
accompanied by counter-transport of one internal K ion [1].
It follows, therefore, that the results reported in this study
may be attributed both to the alteration of SERT transport
function in the conditions used and to the absence of the K
ions in the experimental medium.
The detection of SERT interaction with ligands at the air/
solution interface required higher ligand concentrations than
those usually reported to induce pharmacological responses.
The reduced accessibility of a ligand to its binding site may be
attributed both to steric hindrance at high protein surface
densities and an unfavorable orientation of SERT molecules
at the air/water interface. It seemed, therefore, more accurate
to relate the e¡ect of the ligands to the kinetics of surface
pressure changes, i.e. to the ¢rst rate constants, calculated
from Eq. 2. The k values for the studied ligands are presented
in Table 1. It is interesting to note that for all studied ligands,
the k values were invariable with bulk concentration and re-
mained in the limits of the calculated standard deviations. The
obtained k values clearly show that indalpine, paroxetine and
imipramine interact with SERT di¡erently than cocaine and
pinoline. Interestingly, this discrimination of the ligands in the
two groups is the same as that deduced from binding experi-
ments (Kd values in Table 1). Moreover, for the two hetero-
cyclic ligands (paroxetine and indalpine), the k values were
close one to another. Since these two molecules are known
to bind to the same site of the SERT [15], it was reasonable to
assume that the extent and the rate of SERT conformational
changes were related to the accessibility of the ligand binding
site at the interface and to the protein ability to rearrange
after the ligand binding. Our results show also that whereas
binding of heterocyclic molecules (indalpine, paroxetine) was
solution concentration-dependent, a more complex behavior
was characteristic of pinoline and imipramine.
The inhibitory mechanisms of heterocyclic and tricyclic li-
gands at SERT are poorly understood as yet. These molecules
bind to the transporter protein with high a⁄nity, thereby
preventing substrate translocation, but without being trans-
located themselves. The existence of distinct binding sites for
these two classes of antidepressants on the transporter pro-
tein, involving complex interactions between these sites as well
as with the substrate site, has also been inferred from the
independently carried out pharmacological studies. For the
heterocyclic molecules, the surface tension measurements al-
lowed not only to observe a ligand e¡ect on the conforma-
tional changes of the transporter, but also to compare this
e¡ect for antidepressant drugs such as paroxetine and indal-
pine. The concentration of indalpine in the subphase had to
be 5.6 times higher than that of paroxetine to generate the
same surface pressure (Fig. 2). Interestingly, it should be
noted that for the 5-HT uptake, a similar ratio is obtained
in binding experiments carried out in solution ([Ki;indalpine/
Ki;paroxetine] = 5) [4]. The extent of conformational changes in
SERT seems, therefore, to be related to the inhibitory e¡ect of
the studied drugs.
The triphasic behavior observed with imipramine (increase
in surface pressure up to a threshold concentration followed
by a Z decay) may be explained by the existence of two di¡er-
ent a⁄nity states for binding of tricyclic molecules to SERT
[16], one of them being strictly Na-dependent [17]. It is also
interesting to note that when pinoline interacted with SERT, a
similar triphasic behavior was observed (Fig. 3). We interpret
this ¢nding by the existence of two binding locations for the
ligand on the protein, as already suggested by Airaksinen et
al. [18]. It may be assumed that a conformational protein
change occurs only when each pinoline molecule interacts
with two locations. Thus, whereas at low concentrations, pi-
noline easily interacted with the transporter, at the concentra-
tions above the threshold value (Fig. 3), protein sites appeared
to be shielded by accumulated pinoline molecules that hin-
dered further access to SERT. This resulted in the decrease
in surface pressure up to a steady state value, an onset of
saturation of all binding sites.
All together, our biophysical data ([9] and present report)
assert unambiguously direct interactions between the human
SERT and various ligands, and may explain the functioning
of the transporter in the cell membrane. Indeed, the absence
of any detectable conformational change for the two tested
carried molecules (5-HT and MDMA) would favor the hy-
pothesis of an electroneutral transport instead of a channel-
like mechanism (see [1] for review). The transporter confor-
mation in the cell membrane would naturally allow transport
of molecules such as 5-HT or MDMA. Conversely, the Na-
dependent binding of the other ligands (especially of tricyclic
and heterocyclic antidepressants) would induce transporter
conformational changes and, thus, inhibit transport.
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